This Event has Passed
Tuesday, July 30, 2013
10:00 AM - 10:00 PM
10:00 AM - 10:00 PM See all dates and Times
http://www.audioeducator.com/pharma-biotech/drug-development-via-505-b-2-pathway-073013.html
For more information:- http://www.audioeducator.com/pharma-biotech/drug-development-via-505-b-2-pathway-073013.html Product Format: Live Audio Conference Presenter(s) Dr. Mukesh Kumar
Conference Date: Tue, Jul 30, 2013
Aired Time: 1 pm ET | 12 pm CT | 11 am MT | 10 am PT
Length: 90 Minutes
Price: $227
The 505(b) (2) product is a new and improved version of a previously FDA-approved drug. This regulatory pathway offers a pathway to cheaper and faster new drug development, mainly to the manufacturer with experience in developing generic products.
Sign up for this informative session with Dr. Mukesh Kumar, to know the practical strategies for drug development via 505(b)(2) regulatory pathway, key strategic considerations using real-life case studies, market access, reimbursement issues, projected trends for the near future and much more.
Special Offer: Use code EVENT10% to get 10% discount.
For any queries feel free to contact Adam K at 1-866-458-2965 or e-mail Adam at [email protected].
Conference Date: Tue, Jul 30, 2013
Aired Time: 1 pm ET | 12 pm CT | 11 am MT | 10 am PT
Length: 90 Minutes
Price: $227
The 505(b) (2) product is a new and improved version of a previously FDA-approved drug. This regulatory pathway offers a pathway to cheaper and faster new drug development, mainly to the manufacturer with experience in developing generic products.
Sign up for this informative session with Dr. Mukesh Kumar, to know the practical strategies for drug development via 505(b)(2) regulatory pathway, key strategic considerations using real-life case studies, market access, reimbursement issues, projected trends for the near future and much more.
Special Offer: Use code EVENT10% to get 10% discount.
For any queries feel free to contact Adam K at 1-866-458-2965 or e-mail Adam at [email protected].
